Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
8,603 total articles
Charter (CHTR) just cratered after Q1 results that showed lost broadband subs and an EPS miss. Fundamentals and technicals point to more downside before the business stabilizes. This is an actionable short: entry $140.34, stop $156.00, target $95.00, mid-term horizon (45 trading days). Structured risk and a list of catalysts laid out below.
Western Midstream (WES) combines an industry-leading distribution yield (~8%), steady free cash flow ($1.34B last reported) and focused growth initiatives (produced water and NGL/condensate handling) while trading with reasonable valuation metrics (EV/EBITDA ~11.1). For income-oriented traders who want exposure to midstream without the same balance…
Duolingo is swapping short-term monetization for aggressive DAU expansion. Fundamentals remain solid — 39% revenue growth in 2025, $414M net income and 52.7M DAU — and valuation is reasonable for a profitable growth name (P/E ~12.4, EV/S ~3.72). If management can execute on its 100M DAU target by 2028, upside is meaningful. This is a mid-term swing…
WaFd (WAFD) has lagged peers recently but still trades at single-digit P/E relative to earnings power, pays a 3%-plus yield and sits only a few dollars below its recent 52-week high. For traders willing to accept regional-bank refrains on asset quality and expense pressure, a mid-term long makes sense: enter near current levels, keep a tight stop a…
Inventiva (IVA) is a clinical-stage biotech developing lanifibranor, a pan-PPAR oral therapy for metabolic dysfunction-associated steatohepatitis (MASH). With $230.9M in cash and short-term deposits, a market cap near $1.14B, an EASL presentation on 05/27/2026 - 05/30/2026, and a Phase 3 top-line due in Q4 2026, the stock looks like a speculative l…
B2Gold ($BTG) looks set for a re-rating as a recent $325m asset sale to Agnico Eagle, preserved 2026 guidance despite a temporary disruption at Goose and reasonable valuation metrics combine with improving technicals. This trade idea lays out an actionable mid-term (45 trading days) long with clear entry, stop and target levels and a balanced risk …
Micron is the primary beneficiary of AI-driven DRAM and HBM demand. This trade targets a mid-term rebound predicated on continued server upgrades and constrained industry investment. Entry at $110.00, stop $85.00, target $150.00. Horizon: mid term (45 trading days). Risk profile: medium.
Bloom Energy ($BE) is trading well below its recent peak after a parabolic run driven by AI data center demand and large strategic partnerships. The company reported Q1 revenue of $751.1M and raised full-year revenue guidance to $3.4-3.8B, supporting a case for continued growth. That said, the stock trades at very rich revenue multiples today; this…
Microsoft is showing signs of a fundamental inflection: cloud monetization, Copilot AI integration, and a clean balance sheet are translating into accelerating earnings and cash flow. At $421.98 the stock offers a favorable asymmetric trade vs. the 52-week high of $555.45 and the 52-week low of $356.28. This trade plan uses a tested entry, tight st…
Carrefour is executing visible margin-restoration moves that should show through in operating profit over the next two quarters. For traders, the setup is a mid-term long: enter on a pullback, run for ~45 trading days, and use a tight stop to protect against execution slip or macro shocks.
Infleqtion (INFQ) sells neutral-atom quantum sensors, timing and cores. The stock has pulled back after its SPAC debut but sits on real, government-backed revenue and technical integrations (NASA, NVIDIA). At a $2.68B market cap the valuation is aggressive vs. 2025 revenue of roughly $32.5M, but the company’s niche cold-atom IP, growing sensor/timi…
Microsoft is back in the spotlight after a strong run into AI momentum. Fundamentals justify ownership, but technicals and concentrated market expectations create a narrow path for upside. This trade idea recommends a disciplined long with a mid-term horizon, defined entry, stop and target that reflect both bullish catalysts and meaningful risks.
FIW is trading at $100.90 after a sustained pullback. The ETF gives equal-weighted exposure to 36 U.S.-listed water names and sits on a $1.73B market cap. Technicals show oversold conditions while industry-level catalysts - municipal upgrades, M&A and steady dividend yield - argue for a mid-term mean reversion and re-rating. I lay out a clear trade…
Ovintiv (OVV) trades at ~5.3x EV/EBITDA with an enterprise value of roughly $22.8B and a market cap near $16.7B. Trailing free cash flow was negative, but adjusted forward cash generation and recent strategic assets sales/support for the balance sheet make a compelling risk-reward: entry at $59.59, stop $52.00, primary target $71.00 (mid-term, 45 t…
Bar Harbor Bankshares (BHB) offers a balanced risk-reward: modest valuation (P/B ~1.06, P/E ~13.9), a 3.7% yield, and consistent free cash flow. Technical weakness under short-term moving averages gives an actionable entry around $33.50 for a mid-term swing toward $38.00, with a conservative stop at $31.00.
Nebius Group is converting AI demand into outsized revenue growth and a widening moat in AI infrastructure. Strong Q1 results, major long-duration contracts and capacity commitments support a directional long trade with a $330 target over 180 trading days and a protective stop at $185.
Celestica plunged despite beating Q1 results and lifting guidance; fundamentals and a strategic AMD partnership argue for upside. This trade idea lays out an entry at $365, stop at $330 and a target at $435 with a mid-term horizon of 45 trading days.
nLIGHT is a smaller-cap laser specialist that has moved from cyclical optics supplier to a defense-focused beneficiary of directed-energy demand. With accelerating Aerospace & Defense revenue, improving margins, and visible program catalysts, the stock looks tradeable long from current levels. The trade below balances upside to analyst targets with…
Freightos (CRGO) is a small-cap SaaS play in digital freight booking. With a $106M market cap, recent mixed results, and heavy short-volume in May, the stock offers a conservative, asymmetric trade: buy into a transition year where revenue expectations are modest and upside comes from re-acceleration of bookings and margin leverage.
BlackLine is a cash-generative, entrenched finance automation platform that looks mispriced relative to its franchise and free cash flow. Recent AI M&A, engagement from an activist, and a large fund stake create near-term catalysts. Risk is real - leverage and a high headline multiple - but a tactical long with a clear stop and a $40 target fits th…
Core Scientific has shifted the narrative from low-margin self-mining to high-density colocation for AI and blockchain customers. With colocation revenue growing to $65M in 2025, a $500M expansion facility, bullish technicals and concentrated short interest, CORZ offers an asymmetric trade versus legacy peers. This idea lays out an actionable long …
Apple ($AAPL) is trading at fresh highs on persistent services revenue and massive free cash flow. The company’s core hardware franchises plus recurring services form the “three golden apples” that justify a measured long trade. Technicals are stretched, so enter at the current level with a firm stop and a 180 trading-day target that assumes modest…
Citigroup is not only integrating AI into its trading and services franchises but also beginning to show returns that justify a constructive trade. Valuation is reasonable at roughly $212B market cap, earnings per share of $7.63 and an annualized dividend that yields ~1.9%. This trade targets a recovery toward the recent 52-week high while sizing r…
Tarsus reported Q1 XDEMVY sales of $145M, up 85% year-over-year, and reaffirmed full-year guidance of $670-700M. The stock sold off after investors wanted a guidance raise. Fundamentals — rapid revenue growth, very high gross margins and narrowing losses — support a mid-term long trade from a dip toward $64 with a $78 target and a $59 stop.
Boston Scientific (BSX) has been punished hard: the stock trades near $53.40 after a steep move from a $109.50 52-week high. That drawdown has pushed valuation to reasonable levels (P/E ~22, EV/EBITDA ~15.8) while free cash flow remains healthy at roughly $3.48B. For traders willing to take a medium-term view, a disciplined long entry around $53.40…
